![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/4439 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61P 1/16 | (2006.01) |
(11) | Number of the document | 3548026 |
(13) | Kind of document | T |
(96) | European patent application number | 17817175.7 |
Date of filing the European patent application | 2017-12-01 | |
(97) | Date of publication of the European application | 2019-10-09 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
(46) | Date of publication of the claims translation | 2021-05-25 |
(86) | Number | PCT/IB2017/057587 |
Date | 2017-12-01 |
(87) | Number | WO 2018/100557 |
Date | 2018-06-07 |
(30) | Number | Date | Country code |
16382584 | 2016-12-01 | EP |
(72) |
PIZCUETA LALANZA, Maria Pilar, ES
MARTINELL PEDEMONTE, Marc, ES
|
(73) |
Minoryx Therapeutics S.L.,
Av. Ernest Lluch 32, 08302 Mataro , Barcelona,
ES
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | 5-[[4-[2-[5-(1-Hidroksietil)piridin-2-il]etoksi]fenil]metil]-1,3-tiazolidin-2,4-dionas nealkoholinio kepenų suriebėjimo gydymui |
5-[[4-[2-[5-(1-HYDROXYETHYL)PYRIDIN-2-YL]ETHOXY]PHENYL]METHYL]-1,3-THIAZOLIDINE-2,4-DIONE FOR TREATING NONALCOHOLIC FATTY LIVER DISEASE |
Payment date | Validity (years) | Amount | |
2023-11-10 | 7 | 162.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-12-01 |